About this trial
Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parameters (IFNgamma, TNFalpha). These data will be correlated with serum values and disease status. In addition, organoids from duodenal tissue will be isolated and cultured in vitro and stimulated with the major food allergens. The gene and protein expression will be checked to identify relevant biomarkers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
informed consent
patients with suspected food allergy or hypersensitivity
healthy controls with indications for endoscopic diagnostics, e.g. tumour history within the family, exclusion of gastritis
Disqualifiers
pregnant person
Trial design
Parallel
Treatments tested in this trial
biopsy sampling
Other intervention1. Biopsies are homogenised in buffer and used for the determination of mucosal IgE and inflammatory parameters. 2. Biopsies are used to isolate organoids, stimulate them with blood cells and food antigens and to study gene and protein expression.
Treatment groups
Trial outcomes
Primary outcomes
Determination of mucosal IgE to identify patients with gastrointestinal food allergy
Homogenates of mucosal biopsies will be checked for IgE levels
Secondary outcomes
Identification of patients with food hypersensitivity
Homogenates of mucosal biopsies will be checked for inflammatory parameters (TNF, IFN)
Correlation of mucosal IgE and inflammatory parameters with data from organoids
Organoids are isolated from intestinal biopsies, co-cultured with blood cells and stimulated with food antigens. Gene and protein expression will be correlated with mucosal IgE and inflammation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.